These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
353 related articles for article (PubMed ID: 28056085)
1. Vascular Endothelial Over-Expression of Human Soluble Epoxide Hydrolase (Tie2-sEH Tr) Attenuates Coronary Reactive Hyperemia in Mice: Role of Oxylipins and ω-Hydroxylases. Hanif A; Edin ML; Zeldin DC; Morisseau C; Falck JR; Nayeem MA PLoS One; 2017; 12(1):e0169584. PubMed ID: 28056085 [TBL] [Abstract][Full Text] [Related]
2. Effect of Soluble Epoxide Hydrolase on the Modulation of Coronary Reactive Hyperemia: Role of Oxylipins and PPARγ. Hanif A; Edin ML; Zeldin DC; Morisseau C; Nayeem MA PLoS One; 2016; 11(9):e0162147. PubMed ID: 27583776 [TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial overexpression of human CYP2J2 (Tie2-CYP2J2 Tr) modulates cardiac oxylipin profiles and enhances coronary reactive hyperemia in mice. Hanif A; Edin ML; Zeldin DC; Morisseau C; Falck JR; Nayeem MA PLoS One; 2017; 12(3):e0174137. PubMed ID: 28328948 [TBL] [Abstract][Full Text] [Related]
4. Deletion of soluble epoxide hydrolase enhances coronary reactive hyperemia in isolated mouse heart: role of oxylipins and PPARγ. Hanif A; Edin ML; Zeldin DC; Morisseau C; Nayeem MA Am J Physiol Regul Integr Comp Physiol; 2016 Oct; 311(4):R676-R688. PubMed ID: 27488890 [TBL] [Abstract][Full Text] [Related]
5. Reduced coronary reactive hyperemia in mice was reversed by the soluble epoxide hydrolase inhibitor (t-AUCB): Role of adenosine A Hanif A; Edin ML; Zeldin DC; Morisseau C; Falck JR; Ledent C; Tilley SL; Nayeem MA Prostaglandins Other Lipid Mediat; 2017 Jul; 131():83-95. PubMed ID: 28890385 [TBL] [Abstract][Full Text] [Related]
6. Crosstalk between adenosine receptors and CYP450-derived oxylipins in the modulation of cardiovascular, including coronary reactive hyperemic response. Nayeem MA; Hanif A; Geldenhuys WJ; Agba S Pharmacol Ther; 2022 Dec; 240():108213. PubMed ID: 35597366 [TBL] [Abstract][Full Text] [Related]
7. Role of cytochrome P450-epoxygenase and soluble epoxide hydrolase in the regulation of vascular response. Nayeem MA; Geldenhuys WJ; Hanif A Adv Pharmacol; 2023; 97():37-131. PubMed ID: 37236764 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of Human Soluble Epoxide Hydrolase Exacerbates Coronary Reactive Hyperemia Reduction in Angiotensin-II-Treated Mouse Hearts. Hanif A; Edin ML; Zeldin DC; Nayeem MA J Cardiovasc Pharmacol; 2024 Jan; 83(1):46-54. PubMed ID: 37788350 [TBL] [Abstract][Full Text] [Related]
9. Endothelial expression of human cytochrome P450 epoxygenase CYP2C8 increases susceptibility to ischemia-reperfusion injury in isolated mouse heart. Edin ML; Wang Z; Bradbury JA; Graves JP; Lih FB; DeGraff LM; Foley JF; Torphy R; Ronnekleiv OK; Tomer KB; Lee CR; Zeldin DC FASEB J; 2011 Oct; 25(10):3436-47. PubMed ID: 21697548 [TBL] [Abstract][Full Text] [Related]
10. Renal Ischemia/Reperfusion Injury in Soluble Epoxide Hydrolase-Deficient Mice. Zhu Y; Blum M; Hoff U; Wesser T; Fechner M; Westphal C; Gürgen D; Catar RA; Philippe A; Wu K; Bubalo G; Rothe M; Weldon SM; Dragun D; Schunck WH PLoS One; 2016; 11(1):e0145645. PubMed ID: 26727266 [TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial over-expression of soluble epoxide hydrolase (Tie2-sEH) enhances adenosine A Yadav VR; Hong KL; Zeldin DC; Nayeem MA Mol Cell Biochem; 2016 Nov; 422(1-2):197-206. PubMed ID: 27629787 [TBL] [Abstract][Full Text] [Related]
12. Beyond detoxification: a role for mouse mEH in the hepatic metabolism of endogenous lipids. Marowsky A; Meyer I; Erismann-Ebner K; Pellegrini G; Mule N; Arand M Arch Toxicol; 2017 Nov; 91(11):3571-3585. PubMed ID: 28975360 [TBL] [Abstract][Full Text] [Related]
13. Soluble epoxide hydrolase-dependent regulation of myogenic response and blood pressure. Sun D; Cuevas AJ; Gotlinger K; Hwang SH; Hammock BD; Schwartzman ML; Huang A Am J Physiol Heart Circ Physiol; 2014 Apr; 306(8):H1146-53. PubMed ID: 24561863 [TBL] [Abstract][Full Text] [Related]
14. Role of endothelial soluble epoxide hydrolase in cerebrovascular function and ischemic injury. Zhang W; Davis CM; Edin ML; Lee CR; Zeldin DC; Alkayed NJ PLoS One; 2013; 8(4):e61244. PubMed ID: 23585883 [TBL] [Abstract][Full Text] [Related]
15. Epoxyeicosatrienoic and dihydroxyeicosatrienoic acids dilate human coronary arterioles via BK(Ca) channels: implications for soluble epoxide hydrolase inhibition. Larsen BT; Miura H; Hatoum OA; Campbell WB; Hammock BD; Zeldin DC; Falck JR; Gutterman DD Am J Physiol Heart Circ Physiol; 2006 Feb; 290(2):H491-9. PubMed ID: 16258029 [TBL] [Abstract][Full Text] [Related]
18. Altered soluble epoxide hydrolase-derived oxylipins in patients with seasonal major depression: An exploratory study. Hennebelle M; Otoki Y; Yang J; Hammock BD; Levitt AJ; Taha AY; Swardfager W Psychiatry Res; 2017 Jun; 252():94-101. PubMed ID: 28259037 [TBL] [Abstract][Full Text] [Related]
19. Female-favorable attenuation of coronary myogenic constriction via reciprocal activations of epoxyeicosatrienoic acids and nitric oxide. Froogh G; Qin J; Kandhi S; Le Y; Jiang H; Luo M; Sun D; Huang A Am J Physiol Heart Circ Physiol; 2016 Jun; 310(11):H1448-54. PubMed ID: 27016584 [TBL] [Abstract][Full Text] [Related]
20. Role of soluble epoxide hydrolase in postischemic recovery of heart contractile function. Seubert JM; Sinal CJ; Graves J; DeGraff LM; Bradbury JA; Lee CR; Goralski K; Carey MA; Luria A; Newman JW; Hammock BD; Falck JR; Roberts H; Rockman HA; Murphy E; Zeldin DC Circ Res; 2006 Aug; 99(4):442-50. PubMed ID: 16857962 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]